Today, Philips announced a joint development agreement with the Mount Sinai Health System to create a digital image pathology repository containing the digital scans of patient tissue slides and data analytics to pursue the discovery of new tissue-based tests and unlock pathology data. The collaboration aims to advance clinical research and ultimately enable better care for complex diseases, including cancer. Terms of this collaboration agreement were managed by Mount Sinai Innovation Partners, the technology development and commercialization group for the Mount Sinai Health System.
Collaboration Details
Together, Philips and Mount Sinai will create a comprehensive digital image repository containing the digital scans of all these patient glass tissue slides that will be made accessible to researchers. By integrating, analyzing and presenting the data available from whole slide pathology images, clinical laboratory services, genetic analysis, radiology, and surgical and molecular pathology, the data analytics obtained will enable the development of predictive analytics to help personalize patient care. Currently, Mount Sinai Health System comprises seven hospital campuses serving approximately 170,000 inpatients and 2.6 million outpatients annually.
“This collaboration with Philips has the potential to help drive a new paradigm in healthcare that includes the optimization of treatment efficacy and superior clinical outcomes,” said Dr. Carlos Cordon-Cardo M.D., Ph.D., Chairman of the Department of Pathology at the Mount Sinai Health System. “Our ultimate goal with this initiative is to translate data into knowledge to maximize personalized patient management.”
